Your browser doesn't support javascript.
loading
Effects of Bosentan on Hypoxia, Inflammation and Oxidative Stress in Experimental Blunt Thoracic Trauma Model.
Uzun, Nedim; Durmus, Sinem; Gercel, Gonca; Aksu, Burhan; Misirlioglu, Naile Fevziye; Uzun, Hafize.
Afiliación
  • Uzun N; Department of Emergency, Gaziosmanpasa Training and Research Hospital, University of Health Sciences, Istanbul 34098, Turkey.
  • Durmus S; Department of Medical Biochemistry, Faculty of Medicine, Katip Celebi University, Izmir 35620, Turkey.
  • Gercel G; Department of Pediatric Surgery, Istanbul Medeniyet University Göztepe Training and Research Hospital, Istanbul 34730, Turkey.
  • Aksu B; Department of Pediatric Surgery, Istanbul Medeniyet University Göztepe Training and Research Hospital, Istanbul 34730, Turkey.
  • Misirlioglu NF; Department of Biochemistry, Gaziosmanpasa Training and Research Hospital, University of Health Sciences, Istanbul 34098, Turkey.
  • Uzun H; Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34408, Turkey.
Medicina (Kaunas) ; 60(7)2024 Jul 17.
Article en En | MEDLINE | ID: mdl-39064577
ABSTRACT
Background and

Objectives:

In this study, we aimed to investigate the effects of bosentan, an endothelin receptor antagonist, on endothelin-1 (ET-1), hypoxia-inducible factor-1 (HIF-1), nuclear factor-kappa B (NF-κB), and tumor necrosis factor (TNF)-α as inflammation markers, pro-oxidant antioxidant balance (PAB), and total antioxidant capacity (TAC) levels as oxidative stress parameters in lung tissues of rats in an experimental model of pulmonary contusion (PC) induced by blunt thoracic trauma. Materials and

Methods:

Thirty-seven male Sprague-Dawley rats were divided into five groups. C The control group (n = 6) consisted of unprocessed and untreated rats. PC3 (n = 8) underwent 3 days of PC. PC-B3 (n = 8) received 100 mg/kg bosentan and was given orally once a day for 3 days. The PC7 group (n = 7) underwent 7 days of PC, and PC-B7 (n = 8) received 100 mg/kg bosentan and was given orally once a day for 7 days.

Results:

ET-1, NF-κB, TNF-α, HIF-1α, and PAB levels were higher, while TAC activity was lower in all groups compared with the control (p < 0.05). There was no significant difference in ET-1 and TNF-α levels between the PC-B3 and PC-B7 groups and the control group (p < 0.05), while NF-κB, HIF-1α, and PAB levels were still higher in both the PC-B3 and PC-B7 groups than in the control group. Bosentan decreased ET-1, NF-κB, TNF-α, HIF-1α, and PAB and increased TAC levels in comparison to the nontreated groups (p < 0.05).

Conclusions:

Bosentan decreased the severity of oxidative stress in the lungs and reduced the inflammatory reaction in rats with PC induced by blunt thoracic trauma. This suggests that bosentan may have protective effects on lung injury mechanisms by reducing hypoxia, inflammation, and oxidative stress. If supported by similar studies, bosentan can be used in both pulmonary and emergency clinics to reduce ischemic complications, inflammation, and oxidative stress in some diseases that may be accompanied by ischemia.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Traumatismos Torácicos / Heridas no Penetrantes / Ratas Sprague-Dawley / Estrés Oxidativo / Modelos Animales de Enfermedad / Bosentán / Inflamación Límite: Animals Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Traumatismos Torácicos / Heridas no Penetrantes / Ratas Sprague-Dawley / Estrés Oxidativo / Modelos Animales de Enfermedad / Bosentán / Inflamación Límite: Animals Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Turquía